{"id":2864,"date":"2024-10-11T06:25:43","date_gmt":"2024-10-11T06:25:43","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/impurities-in-new-veterinary-medicinal-products-revision\/"},"modified":"2024-10-23T13:16:06","modified_gmt":"2024-10-23T13:16:06","slug":"impurities-in-new-veterinary-medicinal-products-revision","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/es\/guidline\/impurities-in-new-veterinary-medicinal-products-revision\/","title":{"rendered":"Impurezas en los nuevos medicamentos veterinarios (Revisi\u00f3n) VICH"},"content":{"rendered":"<p>VICH GL11(R) (Calidad &#8211; Sustancias impuras) \u2013 Implementado en enero de 2008<\/p>\n","protected":false},"menu_order":149,"template":"","meta":[],"guideline_category":[245],"class_list":["post-2864","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-quality-impurities-es"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline\/2864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/media?parent=2864"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline_category?post=2864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}